(Q46543639)

23 December 2017

title

Effects of the tumour necrosis factor-alpha inhibitors pentoxifylline and thalidomide in short-term experimental oral mucositis in hamsters (English)

1 reference

23 December 2017

0 references

0 references

1 reference

1 reference

Lima V

1

1 reference

23 December 2017

Brito GA

2

1 reference

23 December 2017

Cunha FQ

3

1 reference

23 December 2017

Rebouças CG

4

1 reference

23 December 2017

Falcão BA

5

1 reference

23 December 2017

Augusto RF

6

1 reference

23 December 2017

Souza ML

7

1 reference

23 December 2017

Leitão BT

8

1 reference

23 December 2017

Ribeiro RA

9

1 reference

23 December 2017

publication date

1 June 2005

1 reference

23 December 2017

European Journal of Oral Sciences

published in

1 reference

23 December 2017

volume

113

1 reference

23 December 2017

issue

3

1 reference

23 December 2017

page(s)

210-217

1 reference

23 December 2017

Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice.

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0722.2005.00216.X

Mucositis as a biological process: a new hypothesis for the development of chemotherapy-induced stomatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0722.2005.00216.X

Prevention and management of mucositis in patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0722.2005.00216.X

Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin/tumor necrosis factor synthesis at separate points in the signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0722.2005.00216.X

Thalidomide for the treatment of oral aphthous ulcers in patients with human immunodeficiency virus infection. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0722.2005.00216.X

Transforming growth factor-beta 3 mediated modulation of cell cycling and attenuation of 5-fluorouracil induced oral mucositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0722.2005.00216.X

Pentoxifylline inhibits lipopolysaccharide-induced serum tumor necrosis factor and mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0722.2005.00216.X

Rediscovering thalidomide: a review of its mechanism of action, side effects, and potential uses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0722.2005.00216.X

Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0722.2005.00216.X

Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0722.2005.00216.X

The effect of thalidomide on the pathogenesis of human immunodeficiency virus type 1 and M. tuberculosis infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0722.2005.00216.X

The biological basis for the attenuation of mucositis: the example of interleukin-11.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0722.2005.00216.X

Clinical pharmacology of thalidomide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0722.2005.00216.X

10.1111/J.1600-0722.2005.00216.X

21 January 2018

Identifiers

DOI

1 reference

23 December 2017

1 reference

23 December 2017